Literature DB >> 32445880

White matter hyperintensities are associated with subthreshold amyloid accumulation.

Alexis Moscoso1, David Rey-Bretal2, Jesús Silva-Rodríguez1, Jose M Aldrey3, Julia Cortés4, Juan Pías-Peleteiro3, Álvaro Ruibal1, Pablo Aguiar5.   

Abstract

The association between white matter hyperintensities (WMH) and amyloid accumulation over time in cognitively normal, amyloid-negative elderly people remains largely unexplored. In order to study whether baseline WMH were associated with longitudinal subthreshold amyloid accumulation, 159 cognitively normal participants from the Alzheimer's Disease Neuroimaging Initiative who were amyloid-negative at baseline were examined. All the participants underwent a T1 and a Fluid-Attenuated Inversion Recovery MRI scan at baseline. Amyloid PET imaging was performed at baseline and follow-up visits in 2-year intervals for up to 8 years. Partial volume correction was applied for quantifying cortical Standardised Uptake Value Ratios (SUVR). The associations between global and regional WMH burden and amyloid accumulation were assessed using linear mixed models adjusted by demographic characteristics and baseline SUVR. Partial volume correction increased the measured annual rate of change (+2.4%) compared to that obtained from non-corrected data (+0.5%). There were no significant correlations between baseline WMHs and baseline subthreshold cortical amyloid uptake. In a longitudinal analysis, increased baseline cortical SUVR and increased baseline burden of global (p ​= ​0.006), frontal (p ​= ​0.006), and parietal WMH (p ​= ​0.003) were associated with faster amyloid accumulation. WMH-related amyloid accumulation occurred in parietal, frontal, and, to a lesser extent, cingulate cortices. These results remained unchanged after a sensitivity analysis excluding participants with the highest cortical SUVRs. This is the first study to identify a specific spatial distribution of WMH which is associated with future amyloid accumulation in cognitively normal elderly subjects without PET-detectable amyloid pathology. These findings may have important implications in prevention trials for the early identification of amyloid accumulation.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32445880     DOI: 10.1016/j.neuroimage.2020.116944

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  13 in total

Review 1.  PET imaging of neural activity, β-amyloid, and tau in normal brain aging.

Authors:  Kai Zhang; Hiroshi Mizuma; Xiaohui Zhang; Kayo Takahashi; Chentao Jin; Fahuan Song; Yuanxue Gao; Yousuke Kanayama; Yuping Wu; Yuting Li; Lijuan Ma; Mei Tian; Hong Zhang; Yasuyoshi Watanabe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-05       Impact factor: 9.236

2.  Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.

Authors:  Alexis Moscoso; Michel J Grothe; Michael Schöll
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-21       Impact factor: 9.236

Review 3.  Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease.

Authors:  Rachel F Buckley
Journal:  Neurotherapeutics       Date:  2021-03-29       Impact factor: 7.620

4.  White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer's disease that emerge prior to dementia.

Authors:  Dorothee Schoemaker; Maria Clara Zanon Zotin; Kewei Chen; Kay C Igwe; Clara Vila-Castelar; Jairo Martinez; Ana Baena; Joshua T Fox-Fuller; Francisco Lopera; Eric M Reiman; Adam M Brickman; Yakeel T Quiroz
Journal:  Alzheimers Res Ther       Date:  2022-06-29       Impact factor: 8.823

5.  Regional associations of white matter hyperintensities and early cortical amyloid pathology.

Authors:  Luigi Lorenzini; Loes T Ansems; Isadora Lopes Alves; Silvia Ingala; David Vállez García; Jori Tomassen; Carole Sudre; Gemma Salvadó; Mahnaz Shekari; Gregory Operto; Anna Brugulat-Serrat; Gonzalo Sánchez-Benavides; Mara Ten Kate; Betty Tijms; Alle Meije Wink; Henk J M M Mutsaerts; Anouk den Braber; Pieter Jelle Visser; Bart N M van Berckel; Juan Domingo Gispert; Frederik Barkhof; Lyduine E Collij
Journal:  Brain Commun       Date:  2022-06-15

Review 6.  Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.

Authors:  Dallas P Veitch; Michael W Weiner; Paul S Aisen; Laurel A Beckett; Charles DeCarli; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Susan M Landau; John C Morris; Ozioma Okonkwo; Richard J Perrin; Ronald C Petersen; Monica Rivera-Mindt; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; Duygu Tosun; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2021-09-28       Impact factor: 16.655

7.  Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.

Authors:  Malo Gaubert; Catharina Lange; Gaël Chételat; Miranka Wirth; Antoine Garnier-Crussard; Theresa Köbe; Salma Bougacha; Julie Gonneaud; Robin de Flores; Clémence Tomadesso; Florence Mézenge; Brigitte Landeau; Vincent de la Sayette
Journal:  Alzheimers Res Ther       Date:  2021-01-18       Impact factor: 6.982

8.  Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.

Authors:  Alexis Moscoso; Michel J Grothe; Nicholas J Ashton; Thomas K Karikari; Juan Lantero Rodriguez; Anniina Snellman; Marc Suárez-Calvet; Henrik Zetterberg; Kaj Blennow; Michael Schöll
Journal:  Brain       Date:  2021-02-12       Impact factor: 13.501

9.  A deep semantic segmentation correction network for multi-model tiny lesion areas detection.

Authors:  Yue Liu; Xiang Li; Tianyang Li; Bin Li; Zhensong Wang; Jie Gan; Benzheng Wei
Journal:  BMC Med Inform Decis Mak       Date:  2021-07-30       Impact factor: 2.796

10.  Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology.

Authors:  Kirsty E McAleese; Mohi Miah; Sophie Graham; Georgina M Hadfield; Lauren Walker; Mary Johnson; Sean J Colloby; Alan J Thomas; Charles DeCarli; David Koss; Johannes Attems
Journal:  Acta Neuropathol       Date:  2021-10-04       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.